机构:[1]Department of Medicine, Program in Molecular Medicine, University of Utah, 15 North 2030 East, Salt Lake City, UT 84112, USA[2]Department of Oncological Sciences,University of Utah, Salt Lake City, UT 84112, USA[3]Department of Human Genetics,University of Utah, Salt Lake City, UT 84112, USA[4]Department of Pathology,University of Utah, Salt Lake City, UT 84112, USA[5]ARUP Laboratories,University of Utah, Salt Lake City, UT 84112, USA[6]Navigen Inc., 383 Colorow Drive, Salt Lake City, UT 84108, USA[7]Key Laboratory for Human Disease Gene Study, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, China四川省人民医院[8]Department of Ophthalmology and Shiley Eye Institute, University of California, San Diego, La Jolla, CA 92093, USA[9]VioGen Biosciences LLC, Salt Lake City, UT 84119, USA[10]Mol3D Research LLC, Salt Lake City, UT 84124, USA[11]Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas, MD Anderson Cancer Center, Houston, TX 77054, USA[12]Ocular Oncology Service, Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA[13]Division of Hematology,Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA[14]Division of Cardiovascular Medicine,Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA[15]Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT 84112, USA[16]Department of Cardiology, VA Salt Lake City Health Care System, Salt Lake City, UT 84112, USA
Activating mutations in G alpha q proteins, which form the alpha subunit of certain heterotrimeric G proteins, drive uveal melanoma oncogenesis by triggering multiple downstream signaling pathways, including PLC/PKC, Rho/Rac, and YAP. Here we show that the small GTPase ARF6 acts as a proximal node of oncogenic G alpha q signaling to induce all of these downstream pathways as well as beta-catenin signaling. ARF6 activates these diverse pathways through a common mechanism: the trafficking of GNAQ and beta-catenin from the plasma membrane to cytoplasmic vesicles and the nucleus, respectively. Blocking ARF6 with a small-molecule inhibitor reduces uveal melanoma cell proliferation and tumorigenesis in a mouse model, confirming the functional relevance of this pathway and suggesting a therapeutic strategy for G alpha-mediated diseases.
基金:
NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI); NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); Huntsman Cancer Institute Cell Response and Regulation Program; George S. and Dolores Dore Eccles Foundation; American Asthma Foundation; Burroughs Wellcome FundBurroughs Wellcome Fund; Ben B. and Iris M. Margolis Foundation; H. A. and Edna Benning Fund for Medical Research; Harold J. Lloyd Charitable Trust
第一作者机构:[1]Department of Medicine, Program in Molecular Medicine, University of Utah, 15 North 2030 East, Salt Lake City, UT 84112, USA[2]Department of Oncological Sciences,University of Utah, Salt Lake City, UT 84112, USA
共同第一作者:
通讯作者:
通讯机构:[1]Department of Medicine, Program in Molecular Medicine, University of Utah, 15 North 2030 East, Salt Lake City, UT 84112, USA[2]Department of Oncological Sciences,University of Utah, Salt Lake City, UT 84112, USA[3]Department of Human Genetics,University of Utah, Salt Lake City, UT 84112, USA[5]ARUP Laboratories,University of Utah, Salt Lake City, UT 84112, USA[7]Key Laboratory for Human Disease Gene Study, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, China[14]Division of Cardiovascular Medicine,Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA[16]Department of Cardiology, VA Salt Lake City Health Care System, Salt Lake City, UT 84112, USA
推荐引用方式(GB/T 7714):
Jae Hyuk Yoo,Dallas S. Shi,Allie H. Grossmann,et al.ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma[J].CANCER CELL.2016,29(6):889-904.doi:10.1016/j.ccell.2016.04.015.
APA:
Jae Hyuk Yoo,Dallas S. Shi,Allie H. Grossmann,Lise K. Sorensen,ZongZhong Tong...&Dean Y. Li.(2016).ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma.CANCER CELL,29,(6)
MLA:
Jae Hyuk Yoo,et al."ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma".CANCER CELL 29..6(2016):889-904